Categories: News

EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts

PARIS, Sept. 17, 2025 /PRNewswire/ — A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts.

- Advertisement -

As one of the largest global investigations to examine the link between AE and suicidal ideation, the “Scars of Life” study surveyed 30,801 adults across 27 countries in 2024. Among them, 15,223 were adults with physician-confirmed current AE, while 7,968 adults without AE served as controls. 

- Advertisement -

Participants with current AE were grouped by age of AE onset – childhood, adolescence, or adulthood – and completed a detailed online questionnaire capturing sociodemographic information, self-reported suicidal ideation, severity of itch and skin pain, AE severity, and experiences of skin-related stigmatisation.

- Advertisement -

The results showed that 13.2% of adults with AE reported suicidal ideation, compared with 8.5% of adults without AE. All AE subgroups – whether the condition began in childhood, adolescence, or adulthood – had higher odds of suicidal ideation than controls.

- Advertisement -

Atopic eczema, a chronic inflammatory skin condition affecting more than 200 million people worldwide, is characterised by recurring episodes of dry, itchy and inflamed skin.Beyond the physical symptoms, its impact on mental health is increasingly recognised, with many experiencing anxiety, depression, and social stigma, alongside the daily challenges of managing their condition.

- Advertisement -

Importantly, the study identified several factors strongly associated with suicidal ideation in adults with AE. Younger adults, particularly those under 30, were more likely to report suicidal thoughts (OR=1.6), as were individuals with obesity (OR=1.29).

- Advertisement -

Clinical features also played a major role: moderate-to-severe AE doubled the odds of suicidal ideation (OR=2.01), while pruritus (itching), skin pain, and high overall symptom intensity were all significantly associated with increased risk.

- Advertisement -

Psychosocial and sleep factors further contributed to risk. Adults with suicidal thoughts reported higher levels of stigmatisation and more prevalent sleep disorders, with mixed insomnia – difficulty falling and staying asleep – notably linked to suicidal ideation (OR=1.78).

- Advertisement -

Dr Delphine Kerob, one of the lead researchers, commented, “The results highlight that the effects of atopic eczema are more than skin deep, with suicidal thoughts representing a serious and frequent concern that is often overlooked by healthcare professionals.”

- Advertisement -

“By identifying the main risk factors behind suicidal ideation in this population, we hope this study will help healthcare professionals better recognise and address these challenges, supporting patients’ overall well-being more effectively.”

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/eadv-congress-2025-atopic-eczema-linked-to-significantly-higher-risk-of-suicidal-thoughts-302555081.html

- Advertisement -

Recent Posts

Lumissil Introduces IS32FL3776 Matrix LED Driver for Intelligent Signal Displays

MILPITAS, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Lumissil Microsystems today announced the IS32FL3776 matrix…

6 hours ago

Fushi Fynix and PlayMade Honored at MARKies Awards Singapore 2026 with Two Bronze Wins

SINGAPORE, May 18, 2026 (GLOBE NEWSWIRE) -- The MARKies Awards Singapore 2026, one of the…

6 hours ago

31/2026Trifork Group: Weekly report on share buyback

Schindellegi, Switzerland – 18 May 2026 Trifork Group AGCompany announcement no. 31/2026 Weekly report on…

6 hours ago

Exclusively Sponsored by Sinopec’s Aipao Racing Fuel, the 2026 China Taklimakan Rally Kicks Off in Urumqi

URUMQI, China, May 18, 2026 /PRNewswire/ -- With the command to start, 152 vehicles and…

6 hours ago

AVITA Medical to Host Investor Webinar Briefing

May 17, 2026 18:00 ET  | Source: AVITA Medical VALENCIA, Calif., May 17, 2026 (GLOBE…

11 hours ago

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026

May 17, 2026 16:00 ET  | Source: Design Therapeutics, Inc. CARLSBAD, Calif., May 17, 2026…

11 hours ago